New diagnostic technologies must earn the trust of clinicians, regulators and patients. That trust is built on robust clinical evidence.
Stages of evidence
Evidence typically progresses from early feasibility work to larger validation studies and, ultimately, registry-listed clinical trials with pre-specified outcomes.
Transparency matters
Publishing study details and results as they are confirmed helps the wider community evaluate new technology fairly and supports responsible adoption.
